Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2025 06h30 HE | Source: Merakris Therapeutics

Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer

RESEARCH TRIANGLE PARK, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics has named Roger Ilagan, PhD as its new Chief Scientific Officer (CSO). Responsible for guiding the biologic...
09 févr. 2018 11h03 HE | Source: American College of Rheumatology

American College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps Repeal

Washington, DC, Feb. 09, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology praises Congressional leaders for passing today’s sweeping spending agreement, which includes a technical...
10 août 2017 05h00 HE | Source: BCC Research

Market for Antibody Drug Conjugates to Reach $4.2B by 2021

WELLESLEY, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Technological advancements, the rising incidence of cancer, and an increasing demand for biologic therapies are driving the market for...